NovaBridge Biosciences (NBP) Receivables - Net (2020 - 2022)

NovaBridge Biosciences (NBP) has reported Receivables - Net for 3 consecutive years, with -$5.6 million the latest figure, recorded in Q2 2022.

• In Q2 2022, Receivables - Net fell 131.96% year-over-year to -$5.6 million; the TTM figure through Jun 2022 stood at -$5.6 million (down 131.96% YoY), while the FY2022 annual figure was $4.3 million, down 12.22% from the prior year.
• Receivables - Net declined to -$5.6 million in Q2 2022 per NBP's latest filing, from $4.9 million in the prior quarter.
• Across five years, Receivables - Net topped out at $34.3 million in Q4 2020 and bottomed at -$5.6 million in Q2 2022.
• Historically, Receivables - Net has averaged $7.8 million across 3 years, with a median of $1.3 million in 2021.
• Annual changes were most pronounced in 2021 — Receivables - Net slumped 85.6% — and 2022, when it tumbled 131.96%.
• NovaBridge Biosciences' Receivables - Net stood at $34.3 million in 2020, then plunged by 85.6% to $4.9 million in 2021, then slumped by 212.67% to -$5.6 million in 2022.
• Business Quant data shows NBP's Receivables - Net at -$5.6 million in Q2 2022, $4.9 million in Q4 2021, and -$2.4 million in Q2 2021.